Western blotting showed that in OCI-Ly10S cells, BTK inhibitor PCI-32765 could enhance the apoptosis of non-GCB-DLBCL cells induced by rituximab through down-regulating the phosphorylation of CYLD (Fig. 6e). This evidence concerns the gene BTK and diffuse large B-cell lymphoma.